July 11, 2025
July 14, 2025
This week’s newsletter included:
- BioUtah Spotlights Utah Life Sciences in the UK
- Webinar Recap: Immigration Compliance Under Pressure
- Medical Timeseries Networks Selected as Finalist in U.S. Army xTech AI Grand Challenge
- Merit Medical Names Martha Aronson as New President, CEO
- RefloDx Wins Trans Atlantic Angel Grand Prize
- TEConomy Partners: Utah Life Sciences Workforce Snapshot
- GE HealthCare’s Economic Impact Across Utah
- Deseret News publishes BioUtah Op-Ed on M&A
- Denali Therapeutics: FDA Accepts Priority Review of Biologics License Application for Hunter Syndrome
- BioSeeker™ Developing First-of-Its-Kind Programmable Therapeutic for RSV
- Recursion Acquires Full Rights to a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
- SPARC Health Hosts Second Startup Huddle to Ignite Life Sciences Innovations
- SPARC Health Cohort Program
- Halia Therapeutics Named One of Six Startups Changing the Way We Age
- Canary Speech Earns HITRUST e1 Certification
- Brain-to-Text ’25 Competition
- Nusano Achieves Key Technology Milestone
- Beckerle Steps Down as CEO of Huntsman Cancer Institute
- Paterna Biosciences Selected for Wave 2025 HealthTech|X Accelerator Program
- New Translational Scholars Announced
- University of Utah Founders Day Distinguished Alumni Awards
Featured New Member: SkyDance Vascular, Inc.